조현병 환자의 생애 특질로서 평가된 증상차원과 인지기능 및 다른 임상 특성의 연관성 = Correlation of Lifetime Symptom Dimensions with Cognitive Function and Other Clinical Characteristics in Schizophrenia Patients

다국어 초록 (Multilingual Abstract)

Objectives : Considering large diversity of clinical presentation of schizophrenia, it is important to identify valid clinical subtypes or dimensions that might have homogeneous biological underpinning. The current study aimed to explore lifetime symptom-based dimensional phenotypes in patients with chronic schizophrenia, and to investigate their correlation with cognitive functions and other clinical characteristics.
Methods : Lifetime-based symptoms and additional clinical variables were measured using the Diagnostic Interview for Genetic Studies and the Schedule for the Deficit Syndrome in 315 clinically stable patients with chronic schizophrenia. Through principal components factor analysis, eight dimensional phenotypes were obtained. Comprehensive neuropsychological tests were administered for 103 out of 315 patients, and domain scores were calculated for cognitive domains defined in the MATRICS consensus battery.
Results : ‘Non-paranoid delusion factor’ including delusions of grandiose or religious nature, showed significant negative correlation with processing speed, working memory, attention/vigilance, and general cognitive ability, and positive correlation with intra-individual variability. ‘Negative symptom factor’ showed significant negative correlation only with general cognitive ability. Those two factors were also negatively correlated with function levels measured by Global Assessment Scale (GAS), and associated with poor treatment responses.
Conclusion : Symptom-based dimensional phenotypes of schizophrenia measured on a lifetime basis showed discriminative correlation with cognitive function domains, global functioning level, and overall treatment responses, indicating their possibility as valid phenotype axes of schizophrenia having homogeneous biologic basis.

참고문헌 (Reference)

1 Holtzer R, "Within-person across-neuropsychological test variability and incident dementia" 300 : 823-830, 2008

2 Liddle PF, "The symptoms of chronic schizophrenia. A re-examina-tion of the positive-negative dichotomy" 151 : 145-151, 1987

3 Endicott J, "The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance" 33 : 766-771, 1976

4 Rietkerk T, "The genetics of symptom dimensions of schizophrenia: review and meta-analysis" 102 : 197-205, 2008

5 Nordgaard J, "The diagnostic sta-tus of first-rank symptoms" 34 : 137-154, 2008

6 Kirkpatrick B, "The Schedule for the Deficit syndrome: an instrument for research in schizophrenia" 30 : 119-123, 1989

7 Green MF, "The MATRICS initiative: developing a consensus cognitive battery for clinical trials" 72 : 1-3, 2004

8 Lewandowski KE, "Tactile, olfactory, and gustatory hallucinations in psychotic disor-ders: a descriptive study" 38 : 383-385, 2009

9 Andreasen NC, "Symptoms of schizophrenia. Methods, meanings, and mechanisms" 52 : 341-351, 1995

10 Ventura J, "Symptoms as mediators of the relationship between neurocog-nition and functional outcome in schizophrenia: a meta-analysis" 113 : 189-199, 2009

11 Bilder RM, "Symptomatic and neuropsychological components of defect states" 11 : 409-419, 1985

12 Nopoulos P, "Stabil-ity of cognitive functioning early in the course of schizophrenia" 14 : 29-37, 1994

13 Taylor MA, "Schneiderian first-rank symptoms and clinical prognos-tic features in schizophrenia" 26 : 64-67, 1972

14 Andreasen NC, "Schizophrenia: the characteristic symptoms" 17 : 27-49, 1991

15 Tandon R, "Schizophrenia, “just the facts”what we know in 2008. 2. Epidemiology and etiology" 102 : 1-18, 2008

16 Fanous AH, "Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia" 162 : 1824-1832, 2005

17 Strauss ME, "Relations of symptoms to cognitive deficits in schizo-phrenia" 19 : 215-231, 1993

18 Dunayevich E, "Prevalence and description of psychot-ic features in bipolar mania" 2 : 286-290, 2000

19 Milev P, "Predictive values of neu-rocognition and negative symptoms on functional outcome in schizo-phrenia: a longitudinal first-episode study with 7-year follow-up" 162 : 495-506, 2005

20 Cohen AS, "Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date" 33 : 1201-1212, 2007

21 Bilder RM, "Neuropsychology of first-episode schizophrenia: initial char-acterization and clinical correlates" 157 : 549-559, 2000

22 Carlsson R, "Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis" 113 : 102-111, 2006

23 Gur RE, "Neurocognitive endophenotypes in a multi-plex multigenerational family study of schizophrenia" 164 : 813-819, 2007

24 Heinrichs RW, "Neurocognitive deficit in schizophre-nia: a quantitative review of the evidence" 12 : 426-445, 1998

25 Rabinowitz J, "Negative symptoms have greater impact on function-ing than positive symptoms in schizophrenia: analysis of CATIE data" 137 : 147-150, 2012

26 Bora E, "Meta-analysis of Cognitive Deficits in Ultra-high Risk to Psychosis and First-Episode Psychosis: Do the Cogni-tive Deficits Progress Over, or After, the Onset of Psychosis?" 40 : 744-755, 2014

27 Hughes C, "Longitudinal study of symptoms and cognitive function in chronic schizophrenia" 59 : 137-146, 2003

28 Gold S, "Longitu-dinal study of cognitive function in first-episode and recent-onset schizophrenia" 156 : 1342-1348, 1999

29 Joo EJ, "Ko-rean version of the diagnostic interview for genetic studies: Valid-ity and reliability" 45 : 225-229, 2004

30 Nuechterlein KH, "Identification of separable cognitive factors in schizo-phrenia" 72 : 29-39, 2004

31 Vazza G, "Genome-wide scan supports the existence of a susceptibil-ity locus for schizophrenia and bipolar disorder on chromosome 15q26" 12 : 87-93, 2007

32 Ryu S, "Genome-wide linkage scan of quantitative traits representing symptom di-mensions in multiplex schizophrenia families" 210 : 756-760, 2013

33 Mohamed S, "Gener-alized cognitive deficits in schizophrenia: a study of first-episode patients" 56 : 749-754, 1999

34 Wickham H, "Familiality of symptom dimensions in schizophrenia" 47 : 223-232, 2001

35 McGrath JA, "Familiality of novel factorial dimensions of schizophrenia" 66 : 591-600, 2009

36 노지혜, "Factor Structure of the Neurocognitive Tests: An Application of the Confirmative Factor Analysis in Stabilized Schizophrenia Patients" 대한의학회 25 (25): 276-282, 2010

37 American Psychiatric Association, "Diagnostic And Statistical Manual Of Mental Disorders" American Psychiatric Press 2000

38 American Psychiatric Association, "Diagnostic And Statistical Man-ual of Mental Disorders" American Psychiatric Press 2013

39 Tandon R, "Definition and description of schizophrenia in the DSM-5" 150 : 3-10, 2013

40 Carpenter WT Jr, "Deficit and nondefi-cit forms of schizophrenia: the concept" 145 : 578-583, 1988

41 Vassos E, "Correlation and familial aggregation of dimensions of psychosis in affected sib-ling pairs from China" 193 : 305-310, 2008

42 Elvevag B, "Cognitive impairment in schizophrenia is the core of the disorder" 14 : 1-21, 2000

43 Snitz BE, "Cognitive deficits in un-affected first-degree relatives of schizophrenia patients: a meta-an-alytic review of putative endophenotypes" 32 : 179-194, 2006

44 Guy W, "Clinical global impression scale"

45 Cornblatt BA, "Childhood attentional dysfunctions predict social deficits in unaffected adults at risk for schizophrenia" 59-64, 1992

46 Davidson M, "Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents" 156 : 1328-1335, 1999

47 Finkelstein JR, "Attention-al dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizo-phrenic patients and their siblings" 106 : 203-212, 1997

48 Baek JH, "Association of genetic variations in DTNBP1 with cognitive function in schizo-phrenia patients and healthy subjects" 159B : 841-849, 2012

49 Arai M, "As-sociation between polymorphisms in the promoter region of the si-alyltransferase 8B (SIAT8B) gene and schizophrenia" 59 : 652-659, 2006

50 Peralta V, "Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy" 161 : 335-343, 1992

51 Green MF, "Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria" 56 : 301-307, 2004

52 Yamada N, "Age at onset of delusional dis-order is dependent on the delusional theme" 97 : 122-124, 1998

53 Buchanan RW, "A summary of the FDA-NIMH-MATRICS workshop on clini-cal trial design for neurocognitive drugs for schizophrenia" 31 : 5-19, 2005